Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Philadelphia (BCMA CART + huCART19, CART BCMA or CART BCMA + huCART19, Single-dose infusion of CART

Active, not recruiting
  • Multiple Myeloma
  • BCMA CART + huCART19
  • +2 more
  • Philadelphia, Pennsylvania
    Univ. of Pennsylvania
Jul 11, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Lemzoparlimab
  • +4 more
  • Tucson, Arizona
  • +58 more
Jul 6, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Multiple Myeloma Trial in United States (PT-112)

Completed
  • Multiple Myeloma
  • Phoenix, Arizona
  • +6 more
Apr 19, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Canada, United States (Ibrutinib, Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +16 more
Nov 24, 2021

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
Has Results
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +32 more
Oct 8, 2021

Multiple Myeloma Trial in United States (hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Terminated
  • Multiple Myeloma
  • hLL1-DOX (the doxorubicin conjugate of milatuzumab)
  • Orlando, Florida
  • +4 more
Aug 12, 2021

Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA Trial in United States (milatuzumab)

Completed
  • Multiple Myeloma
  • +2 more
  • milatuzumab
  • Atlanta, Georgia
  • +5 more
Aug 12, 2021

Multiple Myeloma Trial in United States (MyHOPE™ for Multiple Myeloma, MyHope HCP Portal)

Terminated
  • Multiple Myeloma
  • MyHOPE™ for Multiple Myeloma
  • MyHope HCP Portal
  • Mobile, Alabama
  • +33 more
Aug 5, 2021

Advanced Solid Tumors, Multiple Myeloma Trial in Philadelphia (ONC-201)

Completed
  • Advanced Solid Tumors
  • Multiple Myeloma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 2, 2021

Multiple Myeloma Trial in United States (zoledronic acid)

Completed
Has Results
  • Multiple Myeloma
  • zoledronic acid
  • Casa Grande, Arizona
  • +41 more
May 3, 2021

Multiple Myeloma Trial in United States (Oprozomib, Pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Encinitas, California
  • +16 more
Mar 31, 2021

Multiple Myeloma Trial in Philadelphia, Houston (CD3/CD28)

Completed
Has Results
  • Multiple Myeloma
  • CD3/CD28
  • Philadelphia, Pennsylvania
  • +1 more
Dec 2, 2020

Multiple Myeloma, Melanoma, Synovial Sarcoma Trial in Philadelphia (biological, drug, device)

Terminated
  • Multiple Myeloma
  • +3 more
  • NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Oct 9, 2020

Proteasome Inhibition

Completed
  • Heart Failure
  • Multiple Myeloma
    • Philadelphia, Pennsylvania
    • +1 more
    Sep 10, 2020

    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

    Terminated
    • Chronic Myelogenous Leukemia
    • +7 more
    • CD3/CD28 Activated T cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 12, 2020

    Multiple Myeloma Trial in Canada, United Kingdom, United States (GSK2857916)

    Completed
    Has Results
    • Multiple Myeloma
    • Boston, Massachusetts
    • +8 more
    Jul 29, 2020

    Multiple Myeloma Trial in Philadelphia (CART-BCMA)

    Completed
    • Multiple Myeloma
    • CART-BCMA
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Aug 3, 2020

    Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Boston, Massachusetts
    • +4 more
    May 19, 2020